Dan A Oren, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 435 E Main St, Ansonia, CT 06401 Phone: 203-736-2905 Fax: 203-736-8597 |
News Archive
Fresh insight into how the brain responds to medically induced cooling could inform treatments for head injuries and conditions such as stroke.
In a new study on a drug called Stelara (ustekinumab) it was seen that 40% patients with moderate to severe Crohn's disease responded. Stelara, which is already approved to treat psoriasis, is a human interleukin (IL)-12 and IL-23 antagonist marketed by Centocor Ortho Biotech Inc. The study findings were presented at Digestive Disease Week 2011.
The International Society for Cellular Therapy, the global society of clinicians, researchers, regulatory specialists, technologists, and industry partners dedicated to the translation of cellular therapy into safe and effective therapies to improve patients' lives, today announces its reasons for opposition to the current version of the REGROW Act - the US government's legislative efforts to promote faster patient access to effective new cellular therapies.
A hand-held device which could offer point-of-care blood cell analysis in doctors' surgeries is being developed by academics at the University of Southampton and is described in a paper in Lab on a Chip this month.
› Verified 8 days ago